• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

[雌激素治疗前列腺癌的细胞学分化程度的预后意义。496例前列腺癌患者接受雌激素治疗五年的进展控制（作者译）]

[The prognostic significance of cytologic differentiation grades of estrogen-treated prostata carcinoma. Progress control of 496 prostate carcinoma patients treated with estrogen for five years (author's transl)].

作者信息

Faul P, Schmiedt E, Kern R

出版信息

Urologe A. 1978 Nov;17(6):377-81.

PMID:726160
Abstract

The morphologic differentiation grade of cytologic smear preparations proved to be a reliable gradation measurement for the prognosis of 496 patients suffering from prostate cancer and treated with estrogen. Compared with that of other cancer patients, the life expectancy of low-differentiated and anaplastic cancer patients undergoing estrogen treatment is so poor that the rationale of using antiandrogenous treatment in this carcinoma group seems extremely questionable to us. This is why, in view of the predictable prognosis, the differentiation grade of the tumor should be considered when undertaking therapeutic measures.

摘要

细胞学涂片制备的形态学分化分级被证明是496例前列腺癌患者接受雌激素治疗预后的可靠分级指标。与其他癌症患者相比，接受雌激素治疗的低分化和间变癌症患者的预期寿命很差，以至于在这个癌组中使用抗雄激素治疗的合理性对我们来说似乎极有问题。这就是为什么，鉴于可预测的预后，在采取治疗措施时应考虑肿瘤的分化程度。

相似文献

1
[The prognostic significance of cytologic differentiation grades of estrogen-treated prostata carcinoma. Progress control of 496 prostate carcinoma patients treated with estrogen for five years (author's transl)].[雌激素治疗前列腺癌的细胞学分化程度的预后意义。496例前列腺癌患者接受雌激素治疗五年的进展控制（作者译）]
Urologe A. 1978 Nov;17(6):377-81.
2
Prognostic significance of cytological differentiation grading in estrogen-treated prostatic carcinoma diagnosed by fine-needle aspiration biopsy. (Five-year follow-up of 496 patients).经细针穿刺活检诊断的雌激素治疗前列腺癌中细胞学分化分级的预后意义。（496例患者的五年随访）
Int Urol Nephrol. 1980;12(4):347-54. doi: 10.1007/BF02082472.
3
Changes in tissue prostatic acidic phosphatase during endocrine treatment of patients with prostatic carcinoma.前列腺癌患者内分泌治疗期间组织前列腺酸性磷酸酶的变化
Scand J Urol Nephrol. 2005;39(5):393-8. doi: 10.1080/00365590500193304.
4
Focal neuroendocrine differentiation lacks prognostic significance in prostate core needle biopsies.在前列腺穿刺活检中，局灶性神经内分泌分化缺乏预后意义。
J Urol. 1998 Aug;160(2):406-10.
5
[Diagnostic possibilities of the prostate cytology, particularly considering the influence of the cytological degree of differentiation with the prostate carcinoma upon the 5 year survival rate (author's transl)].前列腺细胞学的诊断可能性，尤其考虑前列腺癌的细胞分化程度对5年生存率的影响（作者译）
Arch Geschwulstforsch. 1979;49(1):18-28.
6
[Relationship between androgen and estrogen receptors and clinico-morphological characteristics of prostatic cancer].雄激素与雌激素受体和前列腺癌临床形态学特征之间的关系
Arkh Patol. 1983;45(2):23-8.
7
[Carcinoma of the breast under estrogen-treatment for prostatic carcinoma (author's transl)].前列腺癌雌激素治疗期间并发的乳腺癌（作者译）
Urologe A. 1973 Sep;12(5):249-53.
8
Grading prostate cancer.前列腺癌分级
Am J Clin Pathol. 1994 Oct;102(4 Suppl 1):S38-56.
9
A comprehensive and novel predictive modeling technique using detailed pathology factors in men with localized prostate carcinoma.一种使用局限性前列腺癌男性患者详细病理因素的全面且新颖的预测建模技术。
Cancer. 2002 Oct 1;95(7):1451-6. doi: 10.1002/cncr.10869.
10
Prognostic value of serial tissue prostate-specific antigen measurements during different hormonal treatments in prostate cancer patients.前列腺癌患者在不同激素治疗期间连续组织前列腺特异性抗原测量的预后价值。
Clin Cancer Res. 2000 May;6(5):1790-5.

引用本文的文献

1
Cell kinetic and cytological grading of prostatic carcinoma.前列腺癌的细胞动力学与细胞学分级
Virchows Arch A Pathol Anat Histol. 1981;393(2):205-14. doi: 10.1007/BF00431077.